Market by Gender, Indications, Treatment Type, Sales Channel, and Country | Forecast 2021-2028
The
hair loss treatment market in Europe is likely to develop with a CAGR of 4.96%
over the forecasting years between 2021 and 2028, states a report by Triton
Market Research.
Report scope can be customized per your requirements. Request For Customization
The
countries scrutinized in this market include:
•          The United Kingdom
•          Germany
•          Spain
•          France
•          Italy
•          Russia
•          Rest of Europe countries
German
consumers are extremely concerned about grooming and appearance, and spend
significantly on personal care products, including those for hair care.
Baldness is a major concern among Germans. There has been a rise in the cases
of hair fall and baldness among people here, with a majority of the men opting
for hair transplantation, states the German Medical Group.
Further,
organizations such as the Alopecia Areata Germany eV support and advise
patients suffering from this condition. They also create public awareness about
this disease and promote research on alopecia. All these factors have resulted
in an increase in the demand for hair loss treatment in the country. Thus, the
high consumer spending, growing balding rate, and enhanced consumer awareness
are expected to drive the German hair loss treatment market growth.
People
in France heavily indulge in smoking and alcohol consumption, which is a major
factor contributing to hair loss. Also, diseases like cancer are highly
prevalent in the country, owing to which, there is a large number of people
suffering from alopecia. These factors have led French consumers to increasingly
opt for hair loss treatments, consequently boosting the market growth. Along
with this, the presence of several hair clinics equipped with advanced
technologies, is also contributing to the growth of the market.
Cellmid
is a consumer health company that aims to leverage advanced technologies to
tackle conditions commonly associated with aging. Through its wholly-owned
subsidiaries Kinera, Advangen, and Lyramid, the company develops and markets
novel therapies and diagnostic tests for hair loss, among several other
conditions. évolis® is a clinically validated spray-on product designed by
Cellmid to treat genetic hair loss with minimal side effects, in both men and
women. The company operates in Europe, and recently indulged in a distribution
agreement to further explore the European market.
Market By Type, Application, E ..
VIEW REPORT
Market By Device Type, Therape ..
VIEW REPORT
Market By Type, Application, T ..
VIEW REPORT
Market By Technology, Applicat ..
VIEW REPORT
Market By Application, Type, E ..
VIEW REPORT
Market by Therapeutics, Diagno ..
VIEW REPORT
Market by Type, Application, E ..
VIEW REPORT1. EUROPE
HAIR LOSS TREATMENT MARKET – SUMMARY
2. INDUSTRY
OUTLOOK
2.1. IMPACT
OF COVID-19 ON THE HAIR LOSS TREATMENT INDUSTRY
2.2. KEY
INSIGHTS
2.2.1. EFFORTS
TO DEVELOP STEM CELL HAIR TRANSPLANTATION METHOD
2.2.2. DEVELOPMENT
OF ROBOT HAIR RESTORATION SYSTEM
2.2.3. INTENSIVE
RESEARCH ON 3D PRINTING TECHNOLOGY FOR HAIR
2.3. PORTERS
FIVE FORCES ANALYSIS
2.3.1. THREAT
OF NEW ENTRANTS
2.3.2. THREAT
OF SUBSTITUTE
2.3.3. BARGAINING
POWER OF BUYERS
2.3.4. BARGAINING
POWER OF SUPPLIERS
2.3.5. THREAT
OF COMPETITIVE RIVALRY
2.4. MARKET
ATTRACTIVENESS INDEX
2.5. VENDOR
SCORECARD
2.6. KEY
MARKET STRATEGIES
2.6.1. ACQUISITIONS
2.6.2. PRODUCT
DEVELOPMENTS
2.6.3. CONTRACTS
& AGREEMENTS
2.6.4. INVESTMENT
& EXPANSIONS
2.7. MARKET
DRIVERS
2.7.1. RISE
IN CASES OF AUTOIMMUNE DISEASE
2.7.2. HIGH
CONSUMPTION OF ALCOHOL AND TOBACCO
2.7.3. UNHEALTHY
DIETARY HABITS
2.7.4. STRESS
AND CHANGING LIFESTYLES
2.8. MARKET
CHALLENGES
2.8.1. RISK
OF INFECTION OR SIDE EFFECTS
2.8.2. HIGH
COST OF TREATMENT
2.9. MARKET
OPPORTUNITIES
2.9.1. R&D
IN HAIR CLONING TECHNOLOGY
2.9.2. DEVELOPMENT
OF BARICITINIB
3. EUROPE
HAIR LOSS TREATMENT MARKET OUTLOOK – BY GENDER
3.1. FEMALE
3.2. MALE
4. EUROPE
HAIR LOSS TREATMENT MARKET OUTLOOK – BY INDICATIONS
4.1. ANDROGENIC
ALOPECIA
4.2. ALOPECIA
AREATA
4.3. ALOPECIA
TOTALIS
4.4. OTHER
INDICATIONS
5. EUROPE
HAIR LOSS TREATMENT MARKET OUTLOOK – BY TREATMENT TYPE
5.1. TOPICAL
HAIR LOSS TREATMENT,
5.1.1. MINOXIDIL
5.1.2. SHAMPOOS
5.2. ORAL
HAIR LOSS TREATMENT
5.2.1. FINASTERIDE
5.2.2. OTHER
ORAL HAIR LOSS TREATMENT
5.3. OTHER
TREATMENT TYPES
6. EUROPE
HAIR LOSS TREATMENT MARKET OUTLOOK – BY SALES CHANNEL
6.1. DRUG
STORES & RETAIL PHARMACIES
6.2. HOSPITAL
PHARMACIES
6.3. ONLINE
PHARMACIES
7. EUROPE
HAIR LOSS TREATMENT MARKET – REGIONAL OUTLOOK
7.1. UNITED
KINGDOM
7.2. GERMANY
7.3. FRANCE
7.4. SPAIN
7.5. ITALY
7.6. RUSSIA
7.7. REST
OF EUROPE
8. COMPETITIVE
LANDSCAPE
8.1. TEVA
PHARMACEUTICALS
8.2. MERCK
& CO
8.3. CIPLA LIMITED
8.4. JOHNSON
& JOHNSON
8.5. SUN
PHARMACEUTICAL INDUSTRIES LTD
8.6. CONCERT
PHARMACEUTICALS INC
8.7. SHISEIDO
COMPANY LIMITED
8.8. TAISHO
PHARMACEUTICAL CO LTD
8.9. DR
REDDYS LABORATORIES
8.10. THE
HIMALAYA DRUG COMPANY
8.11. TRANSITIONS
HAIR PVT LTD
8.12. LEXINGTON
INTERNATIONAL LLC
8.13. ACLARIS
THERAPEUTICS
8.14. CELLMID
8.15. DAIICHI
SANKYO
9. RESEARCH
METHODOLOGY & SCOPE
9.1. RESEARCH
SCOPE & DELIVERABLES
9.2. SOURCES
OF DATA
9.3. RESEARCH
METHODOLOGY
TABLE 1: EUROPE HAIR LOSS
TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
TABLE 2: VENDOR SCORECARD
TABLE 3: LIST OF ACQUISITIONS
TABLE 4: LIST OF PRODUCT
DEVELOPMENTS
TABLE 5: LIST OF CONTRACTS
& AGREEMENTS
TABLE 6: LIST OF INVESTMENT
& EXPANSIONS
TABLE 7: EUROPE HAIR LOSS
TREATMENT MARKET, BY GENDER, 2021-2028 (IN $ MILLION)
TABLE 8: EUROPE HAIR LOSS TREATMENT
MARKET, BY INDICATION, 2021-2028 (IN $ MILLION)
TABLE 9: EUROPE HAIR LOSS
TREATMENT MARKET, BY TREATMENT TYPE, 2021-2028 (IN $ MILLION)
TABLE 10: EUROPE HAIR LOSS
TREATMENT MARKET, BY TOPICAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 11: EUROPE HAIR LOSS
TREATMENT MARKET, BY ORAL (TREATMENT) TYPE, 2021-2028 (IN $ MILLION)
TABLE 12: EUROPE HAIR LOSS
TREATMENT MARKET, BY SALES CHANNEL, 2021-2028 (IN $ MILLION)
TABLE 13: EUROPE HAIR LOSS
TREATMENT MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)
FIGURE 1: MARKET
ATTRACTIVENESS INDEX
FIGURE 2: PREVALENCE OF
DIAGNOSED AUTOIMMUNE CONDITIONS IN SELECTED COUNTRIES IN 2019
FIGURE 3: EUROPE HAIR LOSS
TREATMENT MARKET, BY GENDER, 2020 & 2028 (IN %)
FIGURE 4: EUROPE HAIR LOSS
TREATMENT MARKET, BY FEMALE, 2021-2028 (IN $ MILLION)
FIGURE 5: EUROPE HAIR LOSS
TREATMENT MARKET, BY MALE, 2021-2028 (IN $ MILLION)
FIGURE 6: EUROPE HAIR LOSS
TREATMENT MARKET, BY INDICATIONS, 2020 & 2028 (IN %)
FIGURE 7: EUROPE HAIR LOSS
TREATMENT MARKET, BY ANDROGENIC ALOPECIA, 2021-2028 (IN $ MILLION)
FIGURE 8: EUROPE HAIR LOSS
TREATMENT MARKET, BY ALOPECIA AREATA, 2021-2028 (IN $ MILLION)
FIGURE 9: EUROPE HAIR LOSS
TREATMENT MARKET, BY ALOPECIA TOTALIS, 2021-2028 (IN $ MILLION)
FIGURE 10: EUROPE HAIR LOSS
TREATMENT MARKET, BY OTHER INDICATIONS, 2021-2028 (IN $ MILLION)
FIGURE 11: EUROPE HAIR LOSS
TREATMENT MARKET, BY TREATMENT TYPE, 2020 & 2028 (IN %)
FIGURE 12: EUROPE HAIR LOSS
TREATMENT MARKET, BY TOPICAL HAIR LOSS TREATMENT, 2020 & 2028 (IN %)
FIGURE 13: EUROPE HAIR LOSS
TREATMENT MARKET, BY TOPICAL, 2021-2028 (IN $ MILLION)
FIGURE 14: EUROPE HAIR LOSS
TREATMENT MARKET, BY MINOXIDIL, 2021-2028 (IN $ MILLION)
FIGURE 15: EUROPE HAIR LOSS
TREATMENT MARKET, BY SHAMPOOS, 2021-2028 (IN $ MILLION)
FIGURE 16: EUROPE HAIR LOSS TREATMENT
MARKET, BY ORAL HAIR LOSS TREATMENT, 2020 & 2028 (IN %)
FIGURE 17: EUROPE HAIR LOSS
TREATMENT MARKET, BY ORAL, 2021-2028 (IN $ MILLION)
FIGURE 18: EUROPE HAIR LOSS
TREATMENT MARKET, BY FINASTERIDE, 2021-2028 (IN $ MILLION)
FIGURE 19: EUROPE HAIR LOSS
TREATMENT MARKET, BY OTHER ORAL HAIR LOSS TREATMENT, 2021-2028 (IN $ MILLION)
FIGURE 20: EUROPE HAIR LOSS
TREATMENT MARKET, BY OTHERÂ TREATMENT TYPES, 2021-2028 (IN $ MILLION)
FIGURE 21: EUROPE HAIR LOSS
TREATMENT MARKET, BY SALES CHANNEL, 2020 & 2028 (IN %)
FIGURE 22: EUROPE HAIR LOSS
TREATMENT MARKET, BY DRUG STORES & RETAIL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 23: EUROPE HAIR LOSS
TREATMENT MARKET, BY HOSPITAL PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 24: EUROPE HAIR LOSS
TREATMENT MARKET, BY ONLINE PHARMACIES, 2021-2028 (IN $ MILLION)
FIGURE 25: EUROPE HAIR LOSS
TREATMENT MARKET, REGIONAL OUTLOOK, 2020 & 2028 (IN %)
FIGURE 26: UNITED KINGDOM HAIR
LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 27: GERMANY HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 28: FRANCE HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 29: SPAIN HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 30: ITALY HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 31: RUSSIA HAIR LOSS
TREATMENT MARKET 2021-2028 (IN $ MILLION)
FIGURE 32: REST OF EUROPE HAIR
LOSS TREATMENT MARKET 2021-2028 (IN $ MILLION)